Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Sun Pharma Advanced Research Company Ltd

Pharmaceuticals & Biotechnology | Small Cap

Sun Pharma Advanced Research Company Ltd Health Insights
Health Score : 4.35Health Score : 4.35

Sun Pharma Advanced Research Company Ltd, operating within the Healthcare Services sector, demonstrates a mixed financial performance. The company shows strong solvency and some positive growth indicators, particularly in operating profit and EPS. However, it struggles with liquidity, efficiency, coverage, financial metrics, and profitability. Revenue and asset growth have declined, and key profitability margins are significantly negative. The company's high solvency score is contrasted by poor liquidity and profitability, suggesting potential challenges in meeting short-term obligations and generating profit from its operations. Overall, while there are areas of strength, significant improvements are needed to ensure long-term financial stability and growth.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Sun Pharma Advanced Research Company Ltd Health Insights
Health Score : 4.35Health Score : 4.35

Sun Pharma Advanced Research Company Ltd, operating within the Healthcare Services sector, demonstrates a mixed financial performance. The company shows strong solvency and some positive growth indicators, particularly in operating profit and EPS. However, it struggles with liquidity, efficiency, coverage, financial metrics, and profitability. Revenue and asset growth have declined, and key profitability margins are significantly negative. The company's high solvency score is contrasted by poor liquidity and profitability, suggesting potential challenges in meeting short-term obligations and generating profit from its operations. Overall, while there are areas of strength, significant improvements are needed to ensure long-term financial stability and growth.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Neutral

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Neutral

P/E RATIO (TTM)

4.98

Highly Undervalued

Industry Median

28.62

Highly Undervalued
Highly Undervalued

Small Cap Median

27.17

Highly Undervalued

P/E RATIO

4.97

P/B RATIO

5.76

Highly Overvalued

Industry Median

3.17

Highly Overvalued
Highly Overvalued

Small Cap Median

2.62

Highly Overvalued

P/S RATIO

3.79

Neutral

Industry Median

3.42

Neutral
Overvalued

Small Cap Median

2.55

Overvalued

Others

Neutral

PEG RATIO

0.00

Neutral
Undervalued

EV/EBITDA RATIO

4.46

Undervalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹238.09 as on Jun 19, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 7.20

The company exhibits mixed growth signals. While operating profit and EPS growth are positive, revenue and asset growth have declined. This suggests that while the company is improving its profitability, it struggles to expand its revenue base and asset portfolio. Continued focus on innovation and market expansion is crucial for sustained growth.

PoorRevenue Growth RatePoor
ExcellentOperating Profit Growth RateExcellent
ExcellentEarnings Per Share (EPS) GrowthExcellent
PoorAsset Growth RatePoor
ExcellentNet Income Growth RateExcellent
Growth RatiosMar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate-68.2-5.262509.72
Operating Profit Growth Rate87.85-19.65-595.05
Earnings Per Share (EPS) Growth73.91-11.57-553.65
Asset Growth Rate-37.95-34.76546.13
Net Income Growth Rate73.54-11.37-552.77
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 2.00

The company's financial metrics are generally weak. Negative adjusted and cash EPS indicate unprofitability. A negative book value per share is a significant concern, reflecting potential erosion of shareholder equity. Zero dividend per share also suggests that the company is not returning value to shareholders. These factors highlight the need for improved financial performance.

PoorAdjusted Earnings Per Share (Adjusted EPS)Poor
PoorCash Earnings Per Share (Cash EPS)Poor
PoorBook Value Per SharePoor
PoorDividend Per Share (DPS)Poor
PoorCapital Expenditures (CapEx)Poor
Financial RatiosMar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)-6.97-12.12-10.7248.91
Cash Earnings Per Share (Cash EPS)-6.59-11.69-10.3448.84
Book Value Per Share163.91-6.7841.81
Dividend Per Share (DPS)0000
Capital Expenditures (CapEx)14.9269.823.5
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 2.00

The company's profitability ratios are significantly negative across all metrics, including gross profit margin, ROCE, ROE, ROA, operating margin, and net margin. This indicates severe challenges in generating profit from its operations and efficiently utilizing its capital and assets. Addressing these issues is crucial for improving financial health and sustainability.

PoorGross Profit MarginPoor
PoorReturn on Capital Employed (ROCE)Poor
PoorReturn on Equity (ROE)Poor
PoorReturn on Assets (ROA)Poor
PoorOperating MarginPoor
PoorNet MarginPoor
Profitability RatiosMar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin-94.56-546.05-465.2884.57
Return on Capital Employed (ROCE)-40.72-108-279164
Return on Equity (ROE)-43.55-309.6116.07
Return on Assets (ROA)-25.78-78.06-96.1373.65
Operating Margin-89.54-528.95-448.6185.1
Net Margin-93.31-509.21-476.3982.65
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 4.00

The company's efficiency metrics present a mixed picture. The fixed asset and capital turnover ratios are low, indicating inefficient use of assets. The receivables turnover is moderate, but the receivable days suggest some delays in collecting payments. Zero days sales in inventory suggest efficient inventory management. These factors collectively impact the company's operational efficiency.

PoorFixed Asset Turnover RatioPoor
PoorInventory Turnover RatioPoor
WeakReceivables Turnover RatioWeak
ExcellentDays Sales in Inventory RatioExcellent
WeakReceivable DaysWeak
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio2.250.70.7311.97
Inventory Turnover RatioN/AN/AN/AN/A
Receivables Turnover Ratio7.33.14.5156.58
Days Sales in Inventory RatioN/AN/AN/AN/A
Receivable Days50117.7481.112.33
Capital Turnover Ratio0.450.55-0.681.4
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 2.00

The company's coverage ratios are weak, with a negative interest coverage ratio and zero equity dividend coverage. This indicates difficulties in meeting interest obligations and returning value to shareholders through dividends. Addressing these issues is vital for improving investor confidence and financial stability.

PoorInterest Coverage RatioPoor
PoorEquity Dividend Coverage RatioPoor
Coverage RatiosMar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio-26.88-192.5-37.1146.68
Equity Dividend Coverage Ratio
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The company's solvency position is strong, characterized by a negative debt ratio and debt-to-equity ratio, coupled with a high equity ratio. This indicates that the company relies more on equity than debt for financing. A lower debt to asset ratio also suggests strong solvency. This financial structure provides a stable foundation for long-term sustainability and growth.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio0.030.1-1.050
Debt to Equity Ratio0.030.11-0.510
Equity Ratio0.970.92.051
Debt To Asset Ratio0.020.030.330
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 3.10

The company's liquidity position is concerning. While a slightly positive quick ratio offers a small cushion, low current and cash ratios suggest potential difficulties in meeting short-term obligations. Negative operating cash flow further strains liquidity. The industry demands readily available cash for operations and research, making these low ratios a significant challenge.

PoorCurrent RatioPoor
WeakQuick RatioWeak
WeakCash RatioWeak
PoorOperating Cash Flow RatioPoor
Liquidity RatiosMar 2023Mar 2024Mar 2025Mar 2026
Current Ratio1.340.970.412.43
Quick Ratio1.340.970.412.43
Cash Ratio0.370.4100
Operating Cash Flow Ratio-0.23-1.14-0.81-0.29
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 23 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Amrutanjan Health Care Ltd8.2577.37Highly Overvalued31.0020.0321.00
2FDC Ltd7.6422.52Neutral346.0017.56281.00
3Supriya Lifescience Ltd7.4635.88Highly Overvalued294.0025.98209.00
4Aarti Pharmalabs Ltd7.4635.90Neutral369.0019.44175.00
5Innova Captab Ltd7.3638.55Overvalued243.0014.63141.00
6Akums Drugs & Pharmaceuticals Ltd7.2837.30Overvalued522.007.09256.00
7Hikal Ltd7.13-51.71Neutral220.00-3.95-49.00
8RPG Life Sciences Ltd7.1232.70Neutral147.0069.64115.00
9Morepen Laboratories Ltd7.1228.61Neutral126.001.2196.00
10Alembic Ltd7.067.28Undervalued90.004.85317.00
11SMS Pharmaceuticals Ltd5.9434.77Neutral171.009.35102.00
12Shilpa Medicare Ltd5.9444.32Highly Overvalued435.006.80243.00
13Gufic BioSciences Ltd5.4955.51Neutral151.006.3064.00
14Dishman Carbogen Amcis Ltd5.3827.45Neutral566.00-2.4597.00
15IOL Chemicals & Pharmaceuticals Ltd5.3127.76Undervalued269.004.69138.00
16Indoco Remedies Ltd5.26-22.79Neutral142.00-0.61-99.00
17Aarti Drugs Ltd5.0717.34Undervalued309.0018.54195.00
18Orchid Pharma Ltd4.85241.74Neutral41.008.9121.00
19Sequent Scientific Ltd4.61293.05Overvalued162.000.6332.00
20Sun Pharma Advanced Research Company Ltd4.354.97Neutral1599.0047.831553.00
21Solara Active Pharma Sciences Ltd4.34-274.68Neutral187.00-1.50-7.00
22Zota Health Care Ltd3.97-61.25Neutral19.008.06-74.00
Management Assessment Summary
RedWeak Management

The management assessment for Sun Pharma Advanced Research Company Ltd is flagged as Red, indicating significant concerns. The company exhibits negative profitability, reflected in poor OPM and Net Profit margins. Sales have declined substantially, and there's an increasing reliance on borrowings. Returns on Capital Employed (ROCE) and Equity (ROE) are negative, signaling inefficient capital use and poor returns to shareholders. While promoter holding remains high, declining FII interest and a high number of shareholders could indicate a lack of institutional confidence and increased retail interest due to speculative reasons. Overall, the financial performance and capital efficiency metrics suggest significant challenges in management effectiveness.

Category Metric Value Assessment
PROS Promoter Holding 65.68% Shows continued promoter confidence
CONS Sales Growth -5.00% Indicates declining revenue
OPM -450% Reflects poor operational efficiency
ROCE -279% Indicates inefficient use of capital
PoorFinancial Performance & GrowthPoor
WeakCapital Efficiency & ReturnsWeak
PoorFinancial Health & PrudencePoor
AverageShareholding & Ownership StructureAverage
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
RedWeak Risk

The risk assessment for Sun Pharma Advanced Research Company Ltd is flagged as Red due to several critical factors. The company faces significant operational challenges, reflected in its negative profitability and declining sales. Increasing borrowings and negative ROCE indicate heightened financial risk. The inconsistency in quarterly sales and profit growth, alongside a deeply negative operating profit margin, further exacerbates these risks. Declining FII interest adds to the negative outlook. Overall, the combination of poor financials and operational inefficiencies indicates a high-risk profile.

AverageAccounting quality red flagsAverage
01.

Accounting quality red flags

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10240.92Bearish
  3. SMA 20239.61Bearish
  4. SMA 50229.43Bullish
  5. EMA 10239.59Bearish
  6. EMA 20238.35Bearish
  7. EMA 50231.25Bullish
  8. DEMA 10239.82Bearish
  9. DEMA 20242.14Bearish
  10. DEMA 50242.09Bearish
  11. TEMA 10238.81Bearish
  12. TEMA 20240.27Bearish
  13. TEMA 50244.44Bearish
  14. MACD2.48Bearish
  15. ADX53.29Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI52.87Neutral
  3. CCI-83.63Neutral
  4. ROC 9-3.13Bearish
  5. ROC 14-0.66Bearish
  6. ROC 252.19Bullish
  7. Stoch K29.69Neutral
  8. Stoch D31.61Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper244.50Neutral
  3. BB Middle239.61Neutral
  4. BB Lower234.72Neutral
  5. ATR4.23Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI60.51Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10238.94Bearish
  3. SMA 20236.46Bullish
  4. SMA 50221.06Bullish
  5. EMA 10238.32Bearish
  6. EMA 20234.54Bullish
  7. EMA 50223.85Bullish
  8. DEMA 10240.69Bearish
  9. DEMA 20242.49Bearish
  10. DEMA 50239.18Bearish
  11. TEMA 10238.95Bearish
  12. TEMA 20242.76Bearish
  13. TEMA 50240.78Bearish
  14. MACD5.62Bearish
  15. ADX50.75Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI62.38Neutral
  3. CCI19.03Neutral
  4. ROC 9-0.59Bearish
  5. ROC 141.82Bullish
  6. ROC 2516.59Bullish
  7. Stoch K33.97Neutral
  8. Stoch D41.33Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper245.28Neutral
  3. BB Middle236.46Neutral
  4. BB Lower227.65Neutral
  5. ATR5.44Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI69.23Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10236.56Bullish
  3. SMA 20223.44Bullish
  4. SMA 50209.43Bullish
  5. EMA 10234.59Bullish
  6. EMA 20227.15Bullish
  7. EMA 50209.17Bullish
  8. DEMA 10241.94Bearish
  9. DEMA 20239.84Bearish
  10. DEMA 50236.62Bullish
  11. TEMA 10241.96Bearish
  12. TEMA 20241.75Bearish
  13. TEMA 50N/AN/A
  14. MACD9.67Bullish
  15. ADX41.09Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI65.65Neutral
  3. CCI77.02Neutral
  4. ROC 93.43Bullish
  5. ROC 1415.77Bullish
  6. ROC 2519.77Bullish
  7. Stoch K73.58Neutral
  8. Stoch D77.39Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper252.26Neutral
  3. BB Middle223.44Neutral
  4. BB Lower194.62Neutral
  5. ATR8.60Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI82.55Overbought

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 10220.89Bullish
  3. SMA 20216.16Bullish
  4. SMA 50178.26Bullish
  5. SMA 100152.50Bullish
  6. SMA 200144.54Bullish
  7. EMA 10225.33Bullish
  8. EMA 20212.92Bullish
  9. EMA 50186.30Bullish
  10. EMA 100166.31Bullish
  11. EMA 200156.62Bullish
  12. DEMA 10237.97Bullish
  13. DEMA 20234.74Bullish
  14. DEMA 50217.68Bullish
  15. DEMA 100189.61Bullish
  16. DEMA 200158.53Bullish
  17. TEMA 10240.80Bullish
  18. TEMA 20237.52Bullish
  19. TEMA 50234.22Bullish
  20. TEMA 100211.47Bullish
  21. TEMA 200180.11Bullish
  22. MACD16.31Bullish
  23. ADX39.04Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI70.81Overbought
  3. CCI142.55Overbought
  4. ROC 1414.31Bullish
  5. ROC 2543.75Bullish
  6. Stoch K89.33Overbought
  7. Stoch D81.23Overbought
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper247.96Neutral
  3. BB Middle216.16Neutral
  4. BB Lower184.35Neutral
  5. ATR13.56High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI71.94Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 20151.81Bullish
  3. SMA 50144.82Bullish
  4. EMA 20165.07Bullish
  5. EMA 50155.61Bullish
  6. DEMA 20187.08Bullish
  7. DEMA 50149.16Bullish
  8. TEMA 20206.45Bullish
  9. TEMA 50166.99Bullish
  10. MACD19.23Bullish
  11. ADX43.15Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI69.87Neutral
  3. CCI311.69Overbought
  4. ROC 1480.51Bullish
  5. ROC 2555.58Bullish
  6. Stoch K76.90Neutral
  7. Stoch D79.97Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper220.80Overbought
  3. BB Middle151.81Neutral
  4. BB Lower82.82Neutral
  5. ATR22.56High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI90.33Overbought

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 6142.94Bullish
  3. SMA 12142.49Bullish
  4. SMA 24166.72Bullish
  5. EMA 6155.11Bullish
  6. EMA 12152.43Bullish
  7. EMA 24168.27Bullish
  8. DEMA 6168.52Bullish
  9. DEMA 12143.18Bullish
  10. DEMA 24137.45Bullish
  11. TEMA 6184.33Bullish
  12. TEMA 12157.02Bullish
  13. TEMA 24129.12Bullish
  14. MACD-31.40Bullish
  15. ADX11.70Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI50.87Neutral
  3. CCI-12.32Neutral
  4. ROC 25-8.69Bearish
  5. ROC 50-28.57Bearish
  6. Stoch K15.72Oversold
  7. Stoch D12.14Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper219.90Neutral
  3. BB Middle154.71Neutral
  4. BB Lower89.51Neutral
  5. ATR43.61High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI93.17Overbought